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1. Introduction
  Bone mesenchymal stem cell (BMSCs) is able to 
differentiate into endoderm hepatic cells which can resist 
liver fibrosis and protect liver cells. Transplantation of 
exogenous BMSCs can treat hepatic inheritance metabolic 
diseases to some extent. Liver fibrosis is the intermediate 
by which a variety of chronic liver diseases develop into 
cirrhosis. It has been reported that in recent years that 
BMSCs transplantation has a good effect on the treatment 
of liver fibrosis. It can solve donor organ shortage for 
bio-artificial liver transplantation and hepatocyte 
transplantation, and also has a great significance in 
controlling the liver fibrosis[1-3]. 
  However, a variety of factors in the surrounding 
environment will influence and determine the BMSCs 
differentiation direction and lead to the unstable 
therapeutic effects. In this paper, we studied the impact of 
BMSCs on the Smad expression levels of liver fibrosis rats 
and explored their relationship with collagen deposition in 
the live, to analyze the possible molecular mechanisms of 
liver fibrosis in rats from the molecular level.
2. Materials and methods
2.1. Animal model and grouping
  Totally 50 adult female clean grade SD rats were selected, 
8 to 10 weeks old, weighting 80-300 g. All were purchased 
from Shanghai SLAC Laboratory Animal Co. Rats took 
food and water freely in experimental period. Ten rats 
were used as normal control group, the rest 40 rats as liver 
fibrosis model group. The model was established by CCl4 
sc method. 300 mL/L CCl4 paraffin oil solution was injected 
intraperitoneally by 3 mL/kg, 2 times/w for 8 weeks, and two 
rats died during the experiment. A total of 38 CCl4 treated 
SD rats were randomly divided into the observation group 
(n=19): 0.2 mL suspension with BMSCs cell suspension 
(containing 5伊106 cells) were given by tail vein injection at 
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the first 6, 8 w of the modeling; the model group 19 (n=19): 
equivalent normal saline were given by tail vein injection at 
the first 6, 8 w of the modeling; All SD rats were sacrificed 
after 10 w modeling of the liver fibrosis and the liver tissue 
samples were obtained for detection.
2.2. Reagents and instruments
  Lymphocyte separation medium (Shanghai Hua Jing 
Reagent Company), L-DMEM medium (Gibco, USA). Smad3, 
Smad7 and 毬-actin antibody (Santa Cruz, USA), PCR 
primers (Sangon, Shanghai), SYBR Green Mix and reverse 
transcription kit (TOYOBO Corporation, Japan), TGF毬1
immunohistochemistry kit, corollary diluent (1:100) and 
DAB chromogenic agent (all purchased from Wuhan Boster 
Biological Engineering Company), fetal bovine serum 
(Tianjin Hao Yang companies). JEM-1220 transmission 
electron microscope, YLN-2000 gel imaging analysis system, 
Immunohistochemistry kit: TGFlB, smad2, 3 (batch BAl396); 
Smad7 (batch BAl399); corollary diluent (1:100) (batch 
SAl022); DAB chromogenic reagent were all purchased from 
Wuhan Boster Biological Engineering Co.
2.3. BMSCs isolation and culture
  Young male SD rats were collected, marrow suspension 
were isolated from long bone of limbs after 10% chloral 
hydrate anesthesia and routine disinfection. Interface layer 
cells were by absorbed density gradient centrifugation, 
and washed in L-DMEM culture medium twice. Cells were 
collected and inoculated with 1×105/cm2 in 25 cm2 flasks, 
and added with L-DMEM medium which contained 100 U/
mL streptomycin, 100 U/mL penicillin and 10% fetal bovine 
serum. They were cultured in 37℃, 5% CO2 incubator. 
Attachment culture method was used in BMSCs isolation and 
purification. The cells were proliferated.
2.4. Methods
2.4.1. Tissues sample collection
  Blood was extracted by extirpating eyealls, and then rats 
were sacrificed. The blood was centrifuged, and storage in 
the refrigerator. One left lobe and one right lobe of liver were 
obtained, and fixed in 10% neutral formalin. Routine paraffin 
section and HE staining were performed then the tissue was 
observed under the light microscopic.
2.4.2. Serum index detection
  Type 栿 procollagen, 桇 collagen, hyaluronic acid, laminin 
were detected by radioimmunoassay strictly according to the 
instruction of kits.
2.4.3. TGF-毬1 detection
  Serum TGF-毬1 levels was measured by double antibody 
sandwich method. Immunohistochemistry (SP method) was 
used to observe liver TGF-毬1 distribution. Color extent and 
range were analyzed by Olympus Bx50 image analyzer. Ten 
good high power fields of each specimen were selected, and 
brown colored particles were positive staining cells. The 
color degree was 1 (weak), 2 (medium), 3 (strong), and the 
color range was in accordance with the percentage of high-
power field, 1(<25%), 2 (25%-50%), 3(50%-75%), 4(>75%). The 
color rendering index = color degree伊color range.
2.4.4. Smad detection
  PCR detection: Liver tissue total RNA was extrected by 
TRIzol instructions. Transcription the mRNA was reversed 
to cDNA for quantitative PCR reaction. Smad3 upstream 
primer: 5’-CCAGTGCTACCTCCAGTGTr-3‘, downstream: 
5’-CT-GGTGGTCGCTAGnTrCTC -3’; Smad7 upstream: 
5‘-GGCTITCAGATFCCCAACTrC-3’, downstream 5’-
CGCCATCCACTTC-CCTFGT-3‘; internal reference 毬
-actin upstream: 5’-CGTTGACATCCGTA-AAGACCTC-3‘, 
downstream: 5’-rAGGAGCCAGGGCAGTAATCT-3‘. Western 
blot detection method was used to extract total protein of 
liver tissue, then rabbit anti-mouse TGF-毬1 antibody 
(1:200) primary antibody and HRP-conjugated goat anti-
rabbit secondary antibody (1:500) binding reaction was 
carried out after electrophoresis and transmembrane. They 
were incubated avoid light at room temperature for 1 h. The 
membrane was washed to detect 毬-actin expression as an 
internal reference. Fluorescence system scan was used and 
the gray integral value of Smad3, Smad7 protein bands was 
recorded. The ratio of samples integral value and internal 
reference integral value was used for statistical analysis.
2.5. Statistical analysis
  All data were analyzed with SPSS 16.0 software. Data were 
expressed as mean依SD values, the difference between two 
groups were compared with t test. P<0.05 was considered as 
statistical significant difference.
3. Results
3.1. Type 栿 procollagen, 桇 collagen, hyaluronic acid and 
laminin 
  Type 栿 procollagen, 桇 collagen, hyaluronic acid and 
laminin in the observation group and model group were 
significantly higher than the normal control group (P<0.05). 
Type 栿 procollagen, 桇 collagen, hyaluronic acid and 
laminin of the observation group were significantly lower 
than the model group (P<0.05) (Table 1).
3.2. TGF-毬1 level
  The contents and the expression of TGF-毬1 levels in 
serum and liver tissue of the observation group and model 
group were significantly higher than the normal control 
group (P<0.05); The contents and the expression of TGF-毬
1 levels in serum and liver tissue of the observation group 
were significantly lower than the model group (P<0.05) (Table 
2).
3.3. Smad3, Smad4 mRNA expression 
  Compared with the normal control group, the Smad3, Smad4 
mRNA expression of the observation group and model group 
were significantly higher than the normal control group 
(P<0.05). Compared with the model group, the Smad3, Smad4 
mRNA expression of the observation group were significantly 
reduced, the Smad7 mRNA expression was significantly 
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increased (P<0.05) (Table 3).
3.4. Smad3, Smad4 protein expression 
  Compared with the normal control group, the Smad3, Smad4 
protein expression of the observation group and model 
group were significantly higher than the normal control 
group, while the Smad7 protein expression was significantly 
decreased (P<0.05); Compared with the model group, the 
observation group Smad3, Smad4 protein expression was 
significantly reduced, Smad7 protein expression was 
significantly increased (P<0.05) (Table 4).
4. Discussion
  Liver fibrosis is caused by the imbalance of synthesis and 
degradation of extracellular matrix and the overdeposition 
of extracellular matrix, which is the main pathological 
processes from various chronic liver disease to cirrhosis. 
BMSCs are a class of stem cells from mesoderm with 
multipotential differentiation potential. Study confirmed 
that BMSCs can differentiate into chondrocytes, osteoblasts, 
myocardial cells, fat cells and other mesoderm-derived 
tissue cells, but also differentiate into hepatocyte-like cells 
and neuron-like cells from the endoderm and ectoderm[4-7]. 
Tai et al[8] transplanted human BMSCs into allyl alcohol 
induced liver injury rats, and obsered human hepatocyte-
specific alpha-fetoprotein, AGPR, CK18, CK19 and ALB 
expression by immunohistochemistry. It showed human 
BMSCs could be induced into hepatocytes in appropriate 
microenvironment. We observed the effect of BMSCs on 
the Smad expression of liver fibrosis rats, and explored the 
mechanism of BMSCs liver fibrosis reversal effect at the 
molecular level in this study.
  It has been reported that the TGF毬-Smad signaling 
pathway can regulate the damage repair,tumor growth 
and metastasis and other biological behavior is also the 
main message pathway of liver fibrosis[9]. TGF-毬1 plays 
an important role in the process of liver fibrosis, while 
Smads protein as a key post-receptor messenger protein 
that mediates TGF-毬1 signal from the cell membrane to 
nucleus. Smad protein family is involved in the regulation 
cell transformation, proliferation, synthesis, secretion 
and apoptosis, which can be divided into three categories 
in accordance with the different functions: the receptor 
activated SMADs is the target molecules of TGF-毬1 
receptor complex downstream effects; Common type Smad, 
such as Smad4, can combined with receptor-activated Smad 
and plays a role in the TGF-毬1 signal transduction as a 
transit molecules; inhibitory Smad, mainly includes Smad7, 
can inhibit the activation of receptor-activated SMADs 
and block the biological effects of TGF-毬1[10-13]. Studies 
suggest that the adjustment of key Smads molecules level 
expression have an effective anti-fibrotic effect which can 
be used as the assessment index[14].
Table 1
Comparison of hepatic serological markers detection of rats in each group (ng/mL).
Groups Number of cases Type 栿 procollagen Type IV collagen Hyaluronic acid Laminin
Observation group 19  189.4依2.6*#  136.1依3.7*#   215.8依8.3*#   163.3依10.8*#
Model group 19 279.8依3.1* 179.5依4.3*    356.2依10.8*  205.7依16.6*
Normal control group 10  97.1依2.2  48.1依3.1 131.8依7.8 156.4依10.5
Note: Compared with normal control group, * P<0.05; compared with model group, # P<0.05.
Table 2
Contents and the expression of TGF-毬1 levels in serum and liver tissue of two groups.
Groups Number of cases Serum TGF-毬1(毺g/L) Tissue TGF-毬1
Observation group 19   0.73依0.11*#     4.36依1.28*#
Model group 19  1.31依0.15*  10.41依3.45*
Normal control group 10 0.23依0.09   1.00依0.00
Note: Compared with normal control group, * P <0.05; compared with model group, # P <0.05.
Table 3
Comparison of Smad3, Smad4 mRNA expression of two groups
Groups Number of cases Smad3 Smad4 Smad7
Observation group 19   1.48依0.07*#   1.22依0.06*#   0.86依0.09*#
Model group 19  2.13依0.09*  1.53依0.10*  0.41依0.07*
Normal control group 10 1.03依0.06 1.01依0.08 1.00依0.05
Note: Compared with normal control group, * P<0.05; compared with model group, # P<0.05.
Table 4
Comparison of Smad3, Smad4 protein expression of two groups.
Groups Number of cases Smad3 Smad4 Smad7
Observation group 19  0.50依0.06#  0.82依0.18#  0.99依0.13#
Model group 19  0.82依0.10*  1.25依0.12*  0.51依0.10*
Normal control group 10 0.25依0.08 0.91依0.12 1.06依0.16
Note: Compared with normal control group, * P <0.05; compared with model group, # P<0.05.
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  Most reports showed that BMSCs can reduce the liver 
fibrosis. Liang et al[15] found that after 4 weeks of BMSCs 
transplantation for the treatment of CCl4-induced 
hepatic fibrosis in rats, the degree of liver fibrosis can be 
significantly reduced. Zhang  et al[16] found that the level 
of fibrosis in the hepatic lobule was significantly decreased 
after BMSCs transplantation. Zhao[17] found that the serum 
hyaluronic acid, serum type IV collagen and serum type III 
procollagen levels of the mesenchymal stem cells treatment 
group were significantly lower than the model group. This 
study detected the liver serological markers of rat and 
found that the liver tissue structure has been significantly 
improved after BMSCs transplantation. The number of false 
lobe was significantly reduced and the fibrous septa turned 
thinner. 栿 procollagen, 桇 collagen, hyaluronic acid, laminin 
level of the observation group were significantly higher than 
the normal control group. Although the observation group 栿 
procollagen, 桇 collagen, hyaluronic acid, laminin level is still 
significantly higher than the normal control group, the collagen 
fibers in the observation group was significantly reduced 
compared with the model group, the hyaluronic acid, laminin 
levels were also significantly reduced. It showed that BMSCs 
can block the excessive production and deposition of hepatic 
collagen or other extracellular matrix,mitigate and control 
liver fibrosis, also have the degradation effect on the formed 
extracellular matrix.
  The results also show that Smad3, Smad4 mRNA and 
protein expression levels of the model group were 
significantly increased, the difference was significant 
compared with the normal control group(P<0.05), which 
showed the Smad3, Smad4 expression levels were increased 
significantly during rat experimental hepatic fibrosis 
formation. The Smad3, Smad4 mRNA and protein expression 
levels of the observation group were significantly lower than 
the model group, which showed that BMSCs can inhibit 
the Smad3, Smad4 expression to some extent. Xing et al[18] 
considered that Smad3-mediated most of the pro-fibrotic 
effects of TGF毬. Transgenic rat Liver type 栺 collagen 
reduced with the decrease of liver endogenous Smad4 
expression, which showed the inhibition of Smad3, Smad4 
expression has a potential anti-fibrotic effect. Smad7 is an 
antagonistic protein which is able to tightly bind with T毬
RIV, so the binding of Smad2 or Smad3 with T毬RIV were 
blocked by Smad7, and the Smad2 or Smad3 phosphorylation 
were inhibited[19]. By this way, Smad7 can complete the 
inhibition of TGF-毬 signal transduction. Subeq et al[20] 
injected the Smad7cDNA transfection adenovirus vector to 
fibrosis rats and found that 毩-smooth muscle actin and 
liver collagen expression both decreased. In this study, the 
Smad7 mRNA and protein expression of the observation 
group were significantly higher than the model group, which 
showed that BMSCs can increase the expression of Smad7 
and reduce fibrosis from another point of view.
  In summary, injection of BMSCs into the vail vein for liver 
fibrosis rat can significantly improve liver histological 
status. BMSCs can regulate the expression of Smad to some 
extent, and provide a new method chronic liver fibrosis and 
other fibrotic diseases.
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